Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01940172
Title Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors TetraLogic Pharmaceuticals
Indications

fallopian tube cancer

peritoneum cancer

ovarian carcinoma

Therapies

Conatumumab

Birinapant

Age Groups: adult
Covered Countries USA


No variant requirements are available.